Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218036 · ClinicalTrials.gov registry record · Phase 2
Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8
A Phase 2 study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- Phase 2
- Development phase
- 54
- Enrollment target
NCT00218036 is a Phase 2 study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 54 participants.
The verdict
NCT00218036, a Phase 2 study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to examine two medications, modafinil and citalopram, in the treatment of cocaine dependent individuals who are maintained on methadone.
Interventions
- DRUG Placebo
- DRUG Citalopram 20mg
- DRUG Modafinil 200mg
- DRUG Modafinil 400mg
- DRUG Citalopram 40mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2006-07 |
| Est. Completion | 2010-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00218036
The ClinicalTrials.gov registry entry for NCT00218036 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT00218036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00218036 about?
NCT00218036 is a clinical study titled "Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8". The purpose of this study is to examine two medications, modafinil and citalopram, in the treatment of cocaine dependent individuals who are maintained on methadone.
What is the current status of trial NCT00218036?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 54 participants. The study started on 2006-07. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00218036?
The interventions under investigation include: Placebo (DRUG), Citalopram 20mg (DRUG), Modafinil 200mg (DRUG), Modafinil 400mg (DRUG), Citalopram 40mg (DRUG).
Who is sponsoring clinical trial NCT00218036?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.